About Serologicals
Serologicals is a company based in Norcross (United States) founded in 1971 was acquired by Millipore in July 2006. Serologicals has completed 2 acquisitions, including Cytomyx Holdings and Upstate. Serologicals operates in a competitive market with competitors including Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
- Headquarter Norcross, United States
- SectorsHealthcare
- Phone•••• ••••
- Website ww16.serologicals.com/?sub1=20250828-1213-1010-923d-78dde0e2e910
- Social LinkedIn
- Acquired by Millipore (Jul 2006)
- Investors
- Investments & AcquisitionsCytomyx Holdings
& 1 more
- Acquired byMillipore
(Jul 2006)
Investors in Serologicals
Serologicals has secured backing from 1 investor. Prominent investors backing the company include Millipore.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | millipore.com | - |
Investor details for Serologicals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Serologicals
Serologicals has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cytomyx Holdings and Upstate.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cell-based assays for ion channel drug discovery are developed. | cytomyx.com | Cambridge, United Kingdom | 1996 | Mar 2006 | $7M | |
limited information available | upstate.com | – | 1995 | Sep 2004 | $205M |
Complete acquisition details for Serologicals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Serologicals
4 dated milestones of Serologicals across 35 years, from founding to its latest funding, stage changes and deals.
- Founded Serologicals is founded.
- Acquisition Acquires Upstate.
- Acquisition Acquires Cytomyx Holdings.
- Exit Acquired by Millipore.
Competitors of Serologicals
Serologicals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Core Biogenesis, Qkine, Future Fields, Protera and Icon Genetics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| corebiogenesis.com | 2020 | Paris, France | $14.12M | – | UBaaS platform for plant-based recombinant protein bioproduction is offered. | |
| qkine.com | 2016 | Cambridge, United Kingdom | $8.15M | 15 | Animal-free growth factors are developed for life science applications. | |
| futurefields.io | 2017 | Edmonton, Canada | $21.55M | 28 | Serum-free bioactive growth factors and recombinant proteins are biomanufactured. | |
| proterabio.com | 2018 | Sunnyvale, United States | $15.85M | – | Protein-based enzyme technologies are developed using deep learning algorithms. | |
| icongenetics.com | 1999 | Halle, Germany | $14.6M | 25 | Biopharmaceuticals and proteins are developed using green plants as hosts. | |
| algenex.com | 2005 | Madrid, Spain | $13.28M | – | Developer of recombinant biologics for animal and human health | |
| kaicoltd.jp | 2018 | Fukuoka, Japan | $4.37M | – | Manufacturer of portfolio of proteins and other biological cytokines and enzymes | |
| oetltd.com | 2006 | Oxford, United Kingdom | – | 30 | Provides products and services in protein expression | |
| klotho.com | 2016 | San Diego, United States | $10M | – | Patent-pending klotho protein technology is developed for anti-aging applications. | |
| jlandbiotech.com | 2015 | Taizhou, China | – | – | Recombinant proteins are developed for biomedical applications. |
Detailed competitors of Serologicals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Serologicals
10 companies that operate in the same segment as Serologicals (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Serologicals
Serologicals was founded in 1971.
Serologicals is headquartered in Norcross, United States. It is registered at Norcross, Georgia, United States.
Serologicals was founded in 1971 in Norcross, United States, and operates in the biotechnology sector. Laboratory consumables, cell culture supplements, molecular reagents, assays, and diagnostic antibodies are provided for recombinant protein production and cell biology research. Operations extend across Australia, Canada, Scotland, and the United Kingdom. Acquisitions of Bioscot in 1989 and Chemicon International in 2003 were completed, followed by acquisition by Millipore in 2006 to bolster its bioscience division.
Serologicals's top competitors include Future Fields, Qkine and Oxford Expression Technologies.
Serologicals has made 2 acquisitions, including Cytomyx Holdings, and Upstate.
Serologicals has 1 investor. Key investors include Millipore.
Yes. Serologicals was acquired by Millipore in July 2006.